Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

The Impact of RF, and Anti-CCP on RA Patients in Response to Etanercept

This study is to evaluate available local data in Iraqi patients with rheumatoid arthritis on Enbrel treatment with regards to the impact of Rheumatoid factor and Anti-cyclic citrullinated peptide using data from the Baghdad Teaching Hospital registry.

Inclusion Criteria:

• Diagnosed RA patients.

  -≥18 years of age

• Did not receive previous another biological treatment

Exclusion Criteria:

• Had previous biological treatment
• Use of etanercept for less than 1 year